These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21921332)

  • 1. Platelet enzyme abnormalities in leukemias.
    Sharma S; Purohit A; Pati HP; Kochupillai V
    Indian J Cancer; 2011; 48(3):323-7. PubMed ID: 21921332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte enzyme abnormalities in leukemias.
    Sharma S; Pati HP
    J Assoc Physicians India; 2006 Jun; 54():453-7. PubMed ID: 16909693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell enzymopathies in leukemias.
    Devi GS; Prasad MH; Pushpavathi K; Reddy PP; Rao DN
    Indian J Exp Biol; 1996 Dec; 34(12):1224-8. PubMed ID: 9246916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte glucose 6 phosphate dehydrogenase as prognostic indicator in ANLL and CML.
    Devi GS; Prasad MH; Reddy PP; Rao DN
    Indian J Exp Biol; 1997 Feb; 35(2):155-8. PubMed ID: 9315224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on correlation and clinical significance of superoxide dismutase (SOD) activity and content in 102 patients with leukemia].
    Zhu CS; Zhang CY; Weng WQ
    Zhonghua Zhong Liu Za Zhi; 1994 Jan; 16(1):39-42. PubMed ID: 8033747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function in acute leukemias.
    Naresh KN; Sivasankaran P; Veliath AJ
    J Assoc Physicians India; 1993 Jun; 41(6):377-8. PubMed ID: 8005978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood viscosity parameter correlation with types of leukemia.
    Sharma K; Puniyani RR; Bhat SV; Advani SH; Hegde U; Rao S
    Physiol Chem Phys Med NMR; 1992; 24(2):159-64. PubMed ID: 1508991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hexokinase activity of erythrocytes in cancer patients].
    Sensini A; Braussi M; Spadoni M; Giacchi R
    Quad Sclavo Diagn; 1981 Dec; 17(4):431-7. PubMed ID: 7347823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of protease-activated receptor 1 (PAR-1) in human leukemias.
    Veiga Cde S; Carneiro-Lobo TC; Coelho CJ; Carvalho SM; Maia RC; Vasconcelos FC; Abdelhay E; Mencalha AL; Ferreira AF; Castro FA; Monteiro RQ
    Blood Cells Mol Dis; 2011 Mar; 46(3):230-4. PubMed ID: 21216163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Trenn G; Schmidt O; Nahler M; Schaefer UW
    Bone Marrow Transplant; 1999 Apr; 23(8):771-7. PubMed ID: 10231138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
    Fyles GM; Messner HA; Lockwood G; Curtis JE; Rider W; Minden MD; Meharchand JM; Lipton J; Tritchler D; Van Dyk J
    Bone Marrow Transplant; 1991 Dec; 8(6):453-63. PubMed ID: 1790425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red cell enzymes in acute leukemia in relapse & remission.
    Kochupillai V; Scott CW; Moreno H; Gams RA
    Indian J Med Res; 1983 Sep; 78():377-83. PubMed ID: 6585349
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC
    Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
    Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
    Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.